Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

3.0K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.0K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

386
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
386
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

195
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
195
Asthma-I: Introduction01:29

Asthma-I: Introduction

2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

271
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
271

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sustained asthma control and remission in real-world patients with severe eosinophilic asthma receiving benralizumab: XALOC-2.

The Journal of asthma : official journal of the Association for the Care of Asthma·2026
Same author

Heterogeneity of severe asthma in Europe: a SHARP-er view.

The Lancet. Respiratory medicine·2026
Same author

[Documentation of biological treatment in asthma].

Pneumologie (Stuttgart, Germany)·2026
Same author

Enhanced BDNF in Asthma: Does It Overrule Depression?

The journal of allergy and clinical immunology. In practice·2026
Same author

[Clinical and economic role of FeNO measurements in adults with asthma].

Pneumologie (Stuttgart, Germany)·2026
Same author

Clinical phenotyping improves choices of biologics in asthma.

Lancet (London, England)·2026

Related Experiment Video

Updated: Jun 24, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

31.9K

[Modern asthma management].

Marek Lommatzsch

    Deutsche Medizinische Wochenschrift (1946)
    |June 12, 2024
    PubMed
    Summary
    This summary is machine-generated.

    Effective asthma management requires precise patient phenotyping and treating comorbidities. Key strategies include basic measures, disease-modifying anti-asthmatic drugs (DMAADs), and addressing upper airway diseases like allergic rhinitis and chronic rhinosinusitis.

    More Related Videos

    A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
    05:56

    A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

    Published on: May 12, 2023

    3.4K
    Murine Model of Allergen Induced Asthma
    08:05

    Murine Model of Allergen Induced Asthma

    Published on: May 14, 2012

    40.2K

    Related Experiment Videos

    Last Updated: Jun 24, 2025

    Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
    14:39

    Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

    Published on: November 4, 2010

    31.9K
    A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
    05:56

    A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

    Published on: May 12, 2023

    3.4K
    Murine Model of Allergen Induced Asthma
    08:05

    Murine Model of Allergen Induced Asthma

    Published on: May 14, 2012

    40.2K

    Area of Science:

    • Pulmonology and Allergy
    • Respiratory Medicine

    Background:

    • Asthma treatment aims for symptom prevention and remission.
    • Precise patient phenotyping is crucial for successful asthma management.
    • Modern asthma care integrates basic measures, DMAADs, and comorbidity management.

    Purpose of the Study:

    • To highlight the importance of precise phenotyping in asthma.
    • To emphasize the role of disease-modifying anti-asthmatic drugs (DMAADs) in asthma care.
    • To underscore the significance of managing upper airway diseases in asthma patients.

    Main Methods:

    • Patient phenotyping including history, lung function, allergology, and type 2 biomarkers.
    • Implementation of basic asthma management strategies.
    • Application of disease-modifying anti-asthmatic drugs (DMAADs) such as inhaled corticosteroids, biologics, and allergen immunotherapy.
    • Management of comorbidities and upper airway diseases.

    Main Results:

    • Precise phenotyping is an essential prerequisite for successful asthma treatment.
    • DMAADs, including inhaled corticosteroids, biologics, and allergen immunotherapy, are cornerstones of modern asthma management.
    • Treating upper airway diseases like allergic rhinitis and chronic rhinosinusitis is critically important.

    Conclusions:

    • Comprehensive asthma management relies on accurate patient phenotyping.
    • A multi-faceted approach involving DMAADs and comorbidity treatment is essential.
    • Addressing upper airway diseases significantly impacts asthma outcomes, particularly in early- and adult-onset cases.